indications for glp-1 Transformation 2.0: The RAs as Psychiatric Medications? Consensus Recommendations on GLP-1 RA
Description
doi:10.3233/JPD-181329 228
Tirzepatide acts on two receptors (GLP-1 and GIP) and produces stronger appetite suppression and faster weight loss than semaglutide, but it also carries higher rates of early nausea and gastric upset
A handful of nuts here and an extra spoonful of dressing there adds up very quickly
Metabolic Messengers: Glucagon-like peptide 1
.svg?mw=810&hash=8DDE12336D7D7D5D6E4313F13293B26D)
Ongoing clinical trials are evaluating the utility of GLP-1RAs as adjuncts in RA therapy, with particular focus on overweight patient populations [372]
